Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5952 USD | -3.67% | -8.37% | +9.55% |
May. 09 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.55% | 124M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
0.00% | 21.78B | |
-9.51% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wells Fargo Adjusts Price Target on Sangamo Therapeutics to $20 From $22, Maintains Overweight Rating